332 related articles for article (PubMed ID: 32790000)
1. Thrombolytic Agents: Nanocarriers in Controlled Release.
Hassanpour S; Kim HJ; Saadati A; Tebon P; Xue C; van den Dolder FW; Thakor J; Baradaran B; Mosafer J; Baghbanzadeh A; de Barros NR; Hashemzaei M; Lee KJ; Lee J; Zhang S; Sun W; Cho HJ; Ahadian S; Ashammakhi N; Dokmeci MR; Mokhtarzadeh A; Khademhosseini A
Small; 2020 Oct; 16(40):e2001647. PubMed ID: 32790000
[TBL] [Abstract][Full Text] [Related]
2. New developments in thrombolytic therapy.
Collen D; Gold HK
Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
[TBL] [Abstract][Full Text] [Related]
3. Identification and Characterization of Plasmin-Independent Thrombolytic Enzymes.
Hassan MM; Sharmin S; Kim HJ; Hong ST
Circ Res; 2021 Feb; 128(3):386-400. PubMed ID: 33292062
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action and thrombolytic potential of staphylokinase.
Lijnen HR
Verh K Acad Geneeskd Belg; 1995; 57(4):303-14. PubMed ID: 8571666
[TBL] [Abstract][Full Text] [Related]
5. Direct delivery of plasmin using clot-anchoring thrombin-responsive nanoparticles for targeted fibrinolytic therapy.
Sun M; Hao Pontius MH; Yang S; Pendekanti T; Raghunathan S; Shavit JA; Sen Gupta A
J Thromb Haemost; 2023 Apr; 21(4):983-994. PubMed ID: 36696210
[TBL] [Abstract][Full Text] [Related]
6. Bacteria-propelled microtubular motors for efficient penetration and targeting delivery of thrombolytic agents.
Xie S; Mo C; Cao W; Xie S; Li S; Zhang Z; Li X
Acta Biomater; 2022 Apr; 142():49-59. PubMed ID: 35158079
[TBL] [Abstract][Full Text] [Related]
7. Novel and emerging therapies: thrombus-targeted fibrinolysis.
Lippi G; Mattiuzzi C; Favaloro EJ
Semin Thromb Hemost; 2013 Feb; 39(1):48-58. PubMed ID: 23034825
[TBL] [Abstract][Full Text] [Related]
8. Fibrinolytic Enzymes for Thrombolytic Therapy.
Kumar SS; Sabu A
Adv Exp Med Biol; 2019; 1148():345-381. PubMed ID: 31482506
[TBL] [Abstract][Full Text] [Related]
9. The biotechnological potential of fibrinolytic enzymes in the dissolution of endogenous blood thrombi.
Kotb E
Biotechnol Prog; 2014; 30(3):656-72. PubMed ID: 24799449
[TBL] [Abstract][Full Text] [Related]
10. Locally delivered plasmin: why should it be superior to plasminogen activators for direct thrombolysis?
Novokhatny VV; Jesmok GJ; Landskroner KA; Marder VJ; Zimmerman TP
Trends Pharmacol Sci; 2004 Feb; 25(2):72-5. PubMed ID: 15102492
[TBL] [Abstract][Full Text] [Related]
11. Novel Thrombolytic Drug Based on Thrombin Cleavable Microplasminogen Coupled to a Single-Chain Antibody Specific for Activated GPIIb/IIIa.
Bonnard T; Tennant Z; Niego B; Kanojia R; Alt K; Jagdale S; Law LS; Rigby S; Medcalf RL; Peter K; Hagemeyer CE
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28159824
[TBL] [Abstract][Full Text] [Related]
12. New developments in thrombolytic therapy.
Collen DC; Gold HK
Thromb Res Suppl; 1990; 10():105-31. PubMed ID: 2180114
[TBL] [Abstract][Full Text] [Related]
13. Engineering of plasminogen activators for targeting to thrombus and heightening thrombolytic efficacy.
Absar S; Gupta N; Nahar K; Ahsan F
J Thromb Haemost; 2015 Sep; 13(9):1545-56. PubMed ID: 26074048
[TBL] [Abstract][Full Text] [Related]
14. Newer thrombolytic drugs for acute myocardial infarction.
Reddy DS
Indian J Exp Biol; 1998 Jan; 36(1):1-15. PubMed ID: 9536645
[TBL] [Abstract][Full Text] [Related]
15. Thrombolytic therapy.
Collen D; Stump DC; Gold HK
Annu Rev Med; 1988; 39():405-23. PubMed ID: 3130773
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic and clinical characteristics of thrombolytic agents.
Deitcher SR; Jaff MR
Rev Cardiovasc Med; 2002; 3 Suppl 2():S25-33. PubMed ID: 15112713
[TBL] [Abstract][Full Text] [Related]
17. Tissue plasminogen activator-based clot busting: Controlled delivery approaches.
El-Sherbiny IM; Elkholi IE; Yacoub MH
Glob Cardiol Sci Pract; 2014; 2014(3):336-49. PubMed ID: 25780787
[TBL] [Abstract][Full Text] [Related]
18. Thrombolytic Agents: Nanocarriers in Targeted Release.
Shen M; Wang Y; Hu F; Lv L; Chen K; Xing G
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833868
[TBL] [Abstract][Full Text] [Related]
19. Spotlight on reteplase in thrombotic occlusive disorders.
Simpson D; Siddiqui MA; Scott LJ; Hilleman DE
BioDrugs; 2007; 21(1):65-8. PubMed ID: 17263591
[TBL] [Abstract][Full Text] [Related]
20. Historical overview of antithrombotic and thrombolytic therapy.
Sharma GV
Am J Med; 1987 Aug; 83(2A):2-5. PubMed ID: 3307400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
